The DOI matches its Crossref record; 369 of the 369 references it cites were found in a registry or an index.
The A-Z of bacterial translation inhibitors
Abstract
Protein synthesis is one of the major targets in the cell for antibiotics. This review endeavors to provide a comprehensive "post-ribosome structure" A-Z of the huge diversity of antibiotics that target the bacterial translation apparatus, with an emphasis on correlating the vast wealth of biochemical data with more recently available ribosome structures, in order to understand function. The binding site, mechanism of action, and modes of resistance for 26 different classes of protein synthesis inhibitors are presented, ranging from ABT-773 to Zyvox. In addition to improving our understanding of the process of translation, insight into the mechanism of action of antibiotics is essential to the development of novel and more effective antimicrobial agents to combat emerging bacterial resistance to many clinically-relevant drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given that the RNA component of the ribosome plays a critical role in all stages of protein synthesis, translation inhibitors typically bind to rRNA, and consequentially, target-based antibiotic resistance mutations are often associated with discrete rRNA nucleotide changes (2).”
From Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors (2016) · cites this paper as [2]
In the citing paper
“Tetracyclines are broad-spectrum antibiotic agents that bind to elongating ribosomes and inhibit delivery of the ternary complex EF-Tu, GTP and aminoacylated-tRNA (EF-Tu•GTP•aa-tRNA) to the A-site (1).”
From Structural basis for TetM-mediated tetracycline resistance (2012) · cites this paper as [1]
Citations
Cites
Items 201–369 of 369
A Quantitative Kinetic Scheme for 70 S Translation Initiation Complex Formation
Grigoriadou, C., Marzi, S., Kirillov, S. V., Gualerzi, C. O., & Cooperman, B. S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.032 · Cited by 92
Giambattista, M. D., Chinali, G., & COCITO, C. G. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.4.485 · Cited by 92
Celma, M. L., Monro, R. E., & Vázquez, D. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80546-x · Cited by 90
Essential Mechanisms in the Catalysis of Peptide Bond Formation on the Ribosome
Beringer, M., Bruell, C. M., Xiong, L., Pfister, P., Bieling, P., Katunin, V. I., Mankin, A. S., Böttger, E. C., & Rodnina, M. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507961200 · Cited by 90
Improving on nature: antibiotics that target the ribosome
Sutcliffe, J. A. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.004 · Cited by 89
Mutations outside the anisomycin-binding site can make ribosomes drug-resistant
Blaha, G., Gürel, G., Schroeder, S. J., Moore, P. B., & Steitz, T. A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.075 · Cited by 88
A structural view on the mechanism of the ribosome-catalyzed peptide bond formation
Simonović, M., & Steitz, T. A. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.06.006 · Cited by 87
Hygromycin. I. Preliminary studies on the production and biologic activity of a new antibiotic.
Rc, P., Rn, W., Mm, H., et al. (1953) · PubMed · Cited by 87
Species-specific antibiotic-ribosome interactions: implications for drug development
Wilson, D. N., Harms, J., Nierhaus, K. H., Schlünzen, F., & Fucini, P. (2005) · Biological Chemistry · doi:10.1515/bc.2005.141 · Cited by 84
Self-citationInteraction of the antibiotics clindamycin and lincomycin withEscherichia coli23S ribosomal RNA
Douthwaite, S. R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.18.4717 · Cited by 84
Yassin, A., Fredrick, K., & Mankin, A. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508444102 · Cited by 83
[3H]anisomycin binding to eukaryotic ribosomes
Barbacid, M., & Vázquez, D. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90119-3 · Cited by 83
Mankin, A. S. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.08.003 · Cited by 82
Cundliffe, E., Dixon, P. D., Stark, M. J. R., et al. (1979) · Journal of Molecular Biology · doi:10.1016/0022-2836(79)90393-0 · Cited by 81
Siibak, T., Peil, L., Xiong, L., Mankin, A. S., Rèmme, J., & Tenson, T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00870-08 · Cited by 81
The molecular basis for rRNA‐dependent spectinomycin resistance in Nicotiana chloroplasts
Fromm, H., Edelman, M., Aviv, D., et al. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02640.x · Cited by 80
Isolation of kasugamycin resistant mutants in the 16 S ribosomal RNA of Escherichia coli
Vila‐Sanjurjo, A., Squires, C. L., & Dahĺberg, A. E. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3160 · Cited by 80
Structure-based drug design meets the ribosome
Franceschi, F. J., & Duffy, E. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.026 · Cited by 80
Miller, K., Dunsmore, C. J., Fishwick, C. W. G., & Chopra, I. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01015-07 · Cited by 79
Lobritz, M. A., Hutton‐Thomas, R., Marshall, S. H., & Rice, L. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3318-3320.2003 · Cited by 78
Ribosomal Protein L3: Gatekeeper to the A Site
Meškauskas, A., & Dinman, J. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.015 · Cited by 77
Porse, B. T., & Garrett, R. A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2509 · Cited by 76
Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors
Matassova, N., Rodnina, M. V., Endermann, R., et al. (1999) · RNA · doi:10.1017/s1355838299990210 · Cited by 76
The Mode of Action of Pleuromutilin Derivatives
Hodgin, L., & Högenauer, G. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03721.x · Cited by 75
Lincosamides: Chemical Structure, Biosynthesis, Mechanism of Action, Resistance, and Applications
Spížek, J., Novotná, J., & Řezanka, T. (2004) · Advances in applied microbiology · doi:10.1016/s0065-2164(04)56004-5 · Cited by 75
Pestka, S. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.64.2.709 · Cited by 75
Resistance to the Peptidyl Transferase Inhibitor Tiamulin Caused by Mutation of Ribosomal Protein L3
Bøsling, J., Poulsen, S. M., Vester, B., & Long, K. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2892-2896.2003 · Cited by 74
Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
Skripkin, E. A., McConnell, T., DeVito, J., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01193-07 · Cited by 74
The Mode of Action of Pleuromutilin Derivatives
Högenauer, G. (1975) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1975.tb03976.x · Cited by 73
Initiation factor IF 2 binds to the α-sarcin loop and helix 89 of Escherichia coli 23S ribosomal RNA
Teana, A. L., Gualerzi, C. O., & Dahĺberg, A. E. (2001) · RNA · doi:10.1017/s1355838201010366 · Cited by 73
EF-G-Dependent GTPase on the Ribosome. Conformational Change and Fusidic Acid Inhibition
Seo, H., Abedin, S. M., Kamp, D., Wilson, D. N., Nierhaus, K. H., & Cooperman, B. S. (2006) · Biochemistry · doi:10.1021/bi0516677 · Cited by 72
Self-citationIn Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
Lawrence, L. E., Danese, P. N., DeVito, J. A., Franceschi, F. J., & Sutcliffe, J. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01383-07 · Cited by 72
Willie, G. R., Richman, N., Godtfredsen, W. O., et al. (1975) · Biochemistry · doi:10.1021/bi00679a025 · Cited by 71
Resistance to viomycin conferred by RNA of either ribosomal subunit
Yamada, T., MIZUGICHI, Y., Nierhaus, K. H., et al. (1978) · Nature · doi:10.1038/275460a0 · Cited by 71
A new tRNA intermediate revealed on the ribosome during EF4-mediated back-translocation
Connell, S. R., Topf, M., Qin, Y., Wilson, D. N., Mielke, T., Fucini, P., Nierhaus, K. H., & Spahn, C. M. T. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1469 · Cited by 71
Self-citationThompson, J., Cundliffe, E., & Dahĺberg, A. E. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90012-5 · Cited by 69
Brink, M. F., Brink, G., Verbeet, M., & de Boer, H. D. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.3.325 · Cited by 69
Inhibition of Bacterial Ribosome Assembly: a Suitable Drug Target?
Maguire, B. A. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00030-08 · Cited by 69
Long, K. S., Poehlsgaard, J., Hansen, L. H., et al. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06596.x · Cited by 69
Geigenmüller, U., & Nierhaus, K. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07904.x · Cited by 68
Lolk, L., Pøhlsgaard, J., Jepsen, A. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800261u · Cited by 68
Brandi, L., Fabbretti, A., Teana, A. L., Abbondi, M., Losi, D., Donadio, S., & Gualerzi, C. O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507740102 · Cited by 68
Funatsu, G., Schiltz, E., & Wittmann, H. G. (1972) · Molecular and General Genetics MGG · doi:10.1007/bf00332781 · Cited by 67
Ribosomal localization of translation initiation factor IF2
Marzi, S., KNIGHT, W., Brandi, L., Caserta, E., Soboleva, N. G., Hill, W. E., Gualerzi, C. O., & Lodmell, J. S. (2003) · RNA · doi:10.1261/rna.2116303 · Cited by 66
The E-site story: the importance of maintaining two tRNAs on the ribosome during protein synthesis
Wilson, D. N., & Nierhaus, K. H. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6125-4 · Cited by 66
Self-citationHummel, H. S., & Boück, A. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.6.2431 · Cited by 65
McNicholas, P. M., Najarian, D. J., Mann, P. A., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1121-1126.2000 · Cited by 65
Agmon, I., Auerbach, T., Baram, D., Bartels, H., Bashan, A., Berisio, R., Fucini, P., Hansen, H. A. S., Harms, J. M., Kessler, M., et al. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03634.x · Cited by 64
Selective action of erythromycin on initiating ribosomes
Tai, P.-C., Wallace, B., & Davis, B. D. (1974) · Biochemistry · doi:10.1021/bi00719a029 · Cited by 62
Parmeggiani, A., Krab, I. M., Watanabe, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505951200 · Cited by 62
Rasmussen, B. A., Gluzman, Y., & Tally, F. P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1658 · Cited by 62
Meškauskas, A., Petrov, A. N., & Dinman, J. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10863-10874.2005 · Cited by 62
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus
Whitby, M. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00075-2 · Cited by 61
Actinospectacin, a new antibiotic. I. Discovery and biological properties.
Mason, D. J., Dietz, A., & Smith, R. M. (1961) · PubMed · Cited by 61
Recent Developments on Ketolides and Macrolides
Wu, Y.-J., & Su, W.-G. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371671 · Cited by 61
Synthesis and SAR of novel oxazolidinones: Discovery of ranbezolid
Das, B., Rudra, S., Yadav, A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.063 · Cited by 60
Davies, C., Bussiere, D. E., Golden, B. L., Porter, S. J., Ramakrishnan, V., & White, S. W. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1780 · Cited by 59
Porse, B. T., KIRILLOV, S. V., Awayez, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9003 · Cited by 59
Porse, B. T., Cundliffe, E., & Garrett, R. A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2600 · Cited by 59
Dual actions of viomycin on the ribosomal functions
Liou, Y., & Tanaka, N. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90812-3 · Cited by 58
Unusual ribosome binding properties of mRNA encoding bacteriophage λ repressor
Balakin, A. G., Skripkin, E. A., Shatsky, I. N., Bogdanov, A. A., & Belozersky, A. N. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.3.563 · Cited by 58
Structural basis for cross-resistance to ribosomal PTC antibiotics
Davidovich, C., Bashan, A., & Yonath, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810826105 · Cited by 58
Bacterial Ribosomal Subunit Synthesis A Novel Antibiotic Target.
Champney, W. S. (2001) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005013343281 · Cited by 58
Macrolide antibiotic interaction and resistance on the bacterial ribosome.
Poehlsgaard, J., & Douthwaite, S. R. (2003) · PubMed · Cited by 58
Pleuromutilins. Part 1 The identification of novel mutilin 14-carbamates
Brooks, G. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00338-2 · Cited by 56
Besier, S. M., Ludwig, A., Brade, V., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1426-1431.2005 · Cited by 56
Novel Tetrapeptide Inhibitors of Bacterial Protein Synthesis Produced by a Streptomyces sp.
Brandi, L., Lazzarini, A., Cavaletti, L., et al. (2006) · Biochemistry · doi:10.1021/bi052540k · Cited by 55
Shastry, M., NIELSEN, J. B. K., Ku, T., et al. (2001) · Microbiology · doi:10.1099/00221287-147-2-383 · Cited by 55
Thiostrepton inhibition of tRNA delivery to the ribosome
Gonzalez, R. L., Chu, S., & Puglisi, J. D. (2007) · RNA · doi:10.1261/rna.499407 · Cited by 54
Short peptides conferring resistance to macrolide antibiotics
Tenson, T., & Mankin, A. S. (2001) · Peptides · doi:10.1016/s0196-9781(01)00501-0 · Cited by 54
Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli.
Sigmund, C. D., & Morgan, E. A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.18.5602 · Cited by 53
EmtA, a rRNA methyltransferase conferring high‐level evernimicin resistance
Mann, P. A., Xiong, L., Mankin, A. S., et al. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02602.x · Cited by 53
Szaflarski, W., Vesper, O., Teraoka, Y., Plitta-Michalak, B. P., Wilson, D. N., & Nierhaus, K. H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.060 · Cited by 53
Self-citationRelease of (oligo) peptidyl-tRNA from ribosomes by erythromycin A.
Otaka, T., & Kaji, A. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.7.2649 · Cited by 51
Non-ribosomal factors in ribosome subunit assembly are emerging targets for new antibacterial drugs
Comartin, D., & BROWN, E. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.05.005 · Cited by 51
Kalia, V., Miglani, R., Purnapatre, K. P., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00887-08 · Cited by 50
Watanabe, T., Izaki, K., & Takahashi, H. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.1141 · Cited by 50
Thiostrepton-resistant mutants of Thermus thermophilus
Cameron, D. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh644 · Cited by 49
The Translation Initiation Functions of IF2: Targets for Thiostrepton Inhibition
Brandi, L., Marzi, S., Fabbretti, A., Fleischer, C., Hill, W. E., Gualerzi, C. O., & Lodmell, J. S. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.067 · Cited by 48
Tan, G. T., DeBlasio, A., & Mankin, A. S. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0454 · Cited by 48
The Other Target for Ribosomal Antibiotics: Inhibition of Bacterial Ribosomal Subunit Formation
Champney, W. S. (2006) · Infectious Disorders - Drug Targets · doi:10.2174/187152606779025842 · Cited by 48
The Molecular Mechanism of Peptide-mediated Erythromycin Resistance
Lovmar, M., Nilsson, K., Vimberg, V., Tenson, T., Nervall, M., & Ehrenberg, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511918200 · Cited by 46
Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants
Adrian, P. V., Mendrick, C. A., Loebenberg, D., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3101-3106.2000 · Cited by 46
Aarestrup, F. M., & Jensen, L. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3425-3427.2000 · Cited by 45
Kehrenberg, C., & Schwarz, S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00229-07 · Cited by 44
Viomycin, a new tuberculostatic antibiotic.
Bartz, Q. R., EHRLICH, J., Mold, J. D., et al. (1951) · PubMed · doi:10.1164/art.1951.63.1.4 · Cited by 43
Connell, S. R., Trieber, C. A., Stelzl, U., Einfeldt, E., Taylor, D. E., & Nierhaus, K. H. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03115.x · Cited by 42
Ketolide Resistance Conferred by Short Peptides
Tripathi, S., Kloss, P., & Mankin, A. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20073 · Cited by 42
Interaction of Avilamycin with Ribosomes and Resistance Caused by Mutations in 23S rRNA
Kofoed, C. B., & Vester, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3339-3342.2002 · Cited by 42
A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes
Parfait, R., de Béthune, M. P., & COCITO, C. G. (1978) · Molecular and General Genetics MGG · doi:10.1007/bf00379728 · Cited by 42
Thiostrepton resistance mutations in the gene for 23S ribosomal RNA of Halobacteria
Hummel, H. S., & Böck, A. (1987) · Biochimie · doi:10.1016/0300-9084(87)90212-4 · Cited by 42
Overcoming Bacterial Resistance by Dual Target Inhibition: The Case of Streptogramins
Canu, A., & Leclercq, R. (2001) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005014606152 · Cited by 42
Lázaro, E., Rodriguez-Fonseca, C., Porse, B. T., et al. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0455 · Cited by 42
Complex formation of fusidic acid with G factor, ribosome and guanosine nucleotide
Okura, A., Kinoshita, T., & Tanaka, N. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90563-2 · Cited by 41
Hygromycin A, a Novel Inhibitor of Ribosomal Peptidyltransferase
Guerrero, M. D. C., & Modolell, J. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06044.x · Cited by 40
Time-Resolved Binding of Azithromycin to Escherichia coli Ribosomes
Petropoulos, A. D., Kouvela, E. C., Starosta, A. L., Wilson, D. N., Dinos, G. P., & Kalpaxis, D. L. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.11.042 · Cited by 40
Self-citationPulvomycin‐resistant mutants of E.coli elongation factor Tu.
Zeef, L. A. H., Bosch, L., Anborgh, P. H., et al. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06840.x · Cited by 40
HAYASHI, S. F., NORCIA, L. J. L., Seibel, S. B., et al. (1997) · The Journal of Antibiotics · doi:10.7164/antibiotics.50.514 · Cited by 39
Aminoglycoside‐Hybrid Ligands Targeting the Ribosomal Decoding Site
Vourloumis, D., Winters, G. C., Simonsen, K. B., Takahashi, M., Ayida, B. K., Shandrick, S., Zhao, Q., Han, Q., & Hermann, T. (2004) · ChemBioChem · doi:10.1002/cbic.200400197 · Cited by 39
Yassin, A. S., & Mankin, A. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703106200 · Cited by 39
Adrian, P. V., Zhao, W., Black, T. A., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.732-738.2000 · Cited by 39
Novel mutants of 23S RNA: characterization of functional properties
Saarma, U., & Rèmme, J. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.12.3147 · Cited by 39
Rakauskaitė, R., & Dinman, J. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1179 · Cited by 39
Landini, P., Bandera, M., Goldstein, B. P., et al. (1992) · Biochemical Journal · doi:10.1042/bj2830649 · Cited by 37
Conformational changes in switch I of EF‐G drive its directional cycling on and off the ribosome
Ticu, C., Nechifor, R., Nguyen, B., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.169 · Cited by 37
Takashima, H. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452177 · Cited by 37
Rheinberger, H., & Nierhaus, K. H. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19382.x · Cited by 37
Moll, I., & Bläsi, U. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02333-1 · Cited by 37
Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
Parfait, R., & COCITO, C. G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5492 · Cited by 37
The action of virginiamycin M on the acceptor, donor, and catalytic sites of peptidyltransferase.
Chinali, G., Moureau, P., & COCITO, C. G. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42737-2 · Cited by 35
The structure of a methylated tetraloop in 16S ribosomal RNA
Rife, J. P., & Moore, P. B. (1998) · Structure · doi:10.1016/s0969-2126(98)00076-8 · Cited by 35
Retapamulin: A new topical antibiotic for the treatment of uncomplicated skin infections
Parish, L. C., & Parish, J. L. (2008) · Drugs of today · doi:10.1358/dot.2008.44.2.1153446 · Cited by 34
Effects of a Number of Classes of 50S Inhibitors on Stop Codon Readthrough during Protein Synthesis
Thompson, J., Pratt, C. A., & Dahĺberg, A. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4889-4891.2004 · Cited by 34
Dandliker, P. J., Pratt, S. D., Nilius, A. M., Black‐Schaefer, C. L., Ruan, X., Towne, D. L., Clark, R. F., Englund, E. E., Wagner, R., Weitzberg, M., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3831-3839.2003 · Cited by 34
Pactamycin, an antibiotic that inhibits protein synthesis
Bhuyan, B. K. (1967) · Biochemical Pharmacology · doi:10.1016/0006-2952(67)90116-5 · Cited by 33
A new mutation in 16S rRNA ofEscherichia coliconferring spectinomycin resistance
Johanson, U., & Hughes, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.3.464 · Cited by 33
Vimberg, V., Xiong, L., Bailey, M., Tenson, T., & Mankin, A. S. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04290.x · Cited by 33
Vannuffel, P., Giambattista, M. D., & COCITO, C. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41974-6 · Cited by 32
Burghardt, H., Schimz, K.-L., & Müller, M. M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00194-x · Cited by 32
Cross-hypersensitivity Effects of Mutations in 23 S rRNA Yield Insight into Aminoacyl-tRNA Binding
Mankin, A. S., Leviev, I., & Garrett, R. A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1715 · Cited by 32
DORNHELM, P., & Högenauer, G. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12699.x · Cited by 32
Bakker‐Woudenberg, I. A. J. M., van Vianen, W., van Soolingen, D., Verbrugh, H. A., & van Agtmael, M. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2387-2398.2005 · Cited by 32
Bommakanti, A. S., Lindahl, L., & Zengel, J. M. (2008) · RNA · doi:10.1261/rna.786408 · Cited by 32
Chinali, G., Nyssen, E., Giambattista, M. D., et al. (1988) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(88)90056-5 · Cited by 31
Molecular Mechanisms by Which rRNA Mutations Confer Resistance to Clindamycin
Poehlsgaard, J., Pfister, P., Böttger, E. C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1553-1555.2005 · Cited by 31
Pestka, S. (1969) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(69)90345-3 · Cited by 31
SURVEY OF INHIBITORS IN DIFFERENT STEPS OF PROTEIN SYNTHESIS BY MAMMALIAN RIBOSOMES
Carrasco, L., & Vázquez, D. (1972) · The Journal of Antibiotics · doi:10.7164/antibiotics.25.732 · Cited by 31
Isolation and purification of blasticidin s deaminase from Aspergillus terreus.
Yamaguchi, I., SHIBATA, H., Seto, H., et al. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.7 · Cited by 30
Brandi, L., Fabbretti, A., Stefano, M. D., et al. (2006) · RNA · doi:10.1261/rna.61206 · Cited by 30
Resistance of lambda cI translation to antibiotics that inhibit translation initiation
Chin, K., Shean, C. S., & Gottesman, M. E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7471-7473.1993 · Cited by 29
Inhibitory Mechanisms of Antibiotics Targeting Elongation Factor Tu
Hogg, T., Mesters, J. R., & Hilgenfeld, R. (2002) · Current Protein and Peptide Science · doi:10.2174/1389203023380855 · Cited by 29
Schäfer, M. A., Tastan, A. Ö., Patzke, S., Blaha, G. M., Spahn, C. M. T., Wilson, D. N., & Nierhaus, K. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108902200 · Cited by 29
Self-citationWatanabe, T., Izaki, K., & Takahashi, H. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.1148 · Cited by 28
Lázaro, E., den Broek, L. A. G. M. V., San‐Félix, A., et al. (1991) · Biochemistry · doi:10.1021/bi00104a011 · Cited by 28
Characterization of a novel antibacterial agent that inhibits bacterial translation
DDEKER, N. B., Bahador, G., Gibbs, C. S., et al. (2002) · RNA · doi:10.1017/s1355838202024020 · Cited by 28
Wurmbach, P., & Nierhaus, K. H. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07109.x · Cited by 27
Lichtenthaler, F. W., & Trummlitz, G. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80062-1 · Cited by 27
Parfait, R., Giambattista, M. D., & COCITO, C. G. (1981) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(81)90177-5 · Cited by 25
Watanabe, T., Sugiyama, T., Takahashi, M., et al. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.470 · Cited by 25
Effects of Mutations in Ribosomal Protein L16 on Susceptibility and Accumulation of Evernimicin
McNicholas, P. M., Mann, P. A., Najarian, D. J., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.79-83.2001 · Cited by 23
Antibiotics and the Inhibition of Ribosome Function
Wilson, D. N. (2004) · doi:10.1002/3527603433.ch12 · Cited by 22
Self-citationUlbrich, B. C., Mertens, G., & Nierhaus, K. H. (1978) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(78)90262-x · Cited by 22
Douthwaite, S. R., Crain, P. F., Liu, M., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.030 · Cited by 22
Vannuffel, P., Giambattista, M. D., & COCITO, C. G. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.21.4449 · Cited by 22
Polyamines Affect Diversely the Antibiotic Potency
Petropoulos, A. D., Xaplanteri, M. A., Dinos, G. P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313634200 · Cited by 21
Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems
Chinali, G., Nyssen, E., Giambattista, M. D., & COCITO, C. G. (1988) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(88)90023-1 · Cited by 21
Saager, B., Rohde, H., Timmerbeil, B. S., et al. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0514-6 · Cited by 20
Vallabhaneni, H., & Farabaugh, P. J. (2009) · RNA · doi:10.1261/rna.1530509 · Cited by 20
Combinatorial Genetic Technology for the Development of New Anti-infectives
Laios, E., Waddington, M., Saraiya, A. A., et al. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-1351-cgtftd · Cited by 19
Mankin, A. S. (2001) · Molecular Biology · doi:10.1023/a:1010510623805 · Cited by 19
Möhrle, V., Tieleman, L. N., & Kraal, B. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5947 · Cited by 18
Insights into the GTPase Mechanism of EF-Tu from Structural Studies
Hilgenfeld, R., Mesters, J. R., & Hogg, T. (2014) · ASM Press eBooks · doi:10.1128/9781555818142.ch28 · Cited by 17
The production of dihydrospectinomycin by Syreptomyces spect abilis.
Hoeksema, H., & KNIGHT, J. C. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.240 · Cited by 17
Antibiotic inhibition of the movement of tRNA substrates through a peptidyl transferase cavity
Porse, B. T., Rodriguez-Fonseca, C., Leviev, I., et al. (1995) · Biochemistry and Cell Biology · doi:10.1139/o95-095 · Cited by 17
Actinospectacin, a new antibiotic. III. In vitro and in vivo evaluation.
Lewis, C. N., & Clapp, H. W. (1961) · PubMed · Cited by 16
Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes
Giambattista, M. D., Vannuffel, P., Sunazuka, T., et al. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.3.307 · Cited by 15
Nyssen, E., Giambattista, M. D., & COCITO, C. G. (1989) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(89)90076-6 · Cited by 15
Trobicin (Actinospectacin). A New Injectable Antibiotic in the Treatment of Gonorrhoea
Willcox, R. R. (1962) · Sexually Transmitted Infections · doi:10.1136/sti.38.3.150 · Cited by 14
Zarazaga, M., Tenorio, C., del Campo, R., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3657-3659.2002 · Cited by 13
Lázaro, E., van den Broek, L. A. G. M., San‐Félix, A., et al. (1991) · Biochimie · doi:10.1016/0300-9084(91)90157-v · Cited by 13
García-Marcos, A., Morreale, A., Guarinos, E., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm773 · Cited by 12
Actinospectacin, a new antibiotic. II. Microbiological assay.
Hanka, L. J., Dj, M., & Wt, S. (1961) · PubMed · Cited by 12
ACTINOSPECTACIN--A NEW ANTIBIOTIC.
MARSH, R. J., & Fe, C. (1963) · PubMed · Cited by 12
Ziracin-Induced Congenital Urogenital Malformations in Female Rats
Poulet, F. M., Veneziale, R. W., Vancutsem, P. M., et al. (2005) · Toxicologic Pathology · doi:10.1080/01926230590925061 · Cited by 10
Kouvela, E. C., Petropoulos, A. D., & Kalpaxis, D. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603263200 · Cited by 8
Kallia-Raftopoulos, S., & Kalpaxis, D. L. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1042 · Cited by 7
Determination of Eukaryotic Peptidyltransferase Activity by Pseudo-First-Order Kinetic Analysis
Ioannou, M., Coutsogeorgopoulos, C., & Drainas, D. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2034 · Cited by 5
De, B., Smirnova, A. S., Dv, L., et al. (2008) · PubMed · Cited by 5
The States, Conformational Dynamics, and Fusidic Acid-Resistant Mutants of Elongation Factor G
Liljas, A., Kristensen, O., Laurberg, M., et al. (2014) · ASM Press eBooks · doi:10.1128/9781555818142.ch29 · Cited by 3
Research works printed but not linked: 29
- Bartz QR, 1951, Am Rev Tuberc, 63, 4
- Burakovskii DE, 2007, Mol Biol (Mosk), 41, 1031
- Carrasco L, 1972, J Antibiot (Tokyo), 25, 732, 10.7164/antibiotics.25.732 · DOI
- Chinali G, 1988, Biochim Biophys Acta, 949, 71, 10.1016/0167-4781(88)90056-5 · DOI
- 10.1128/AAC.32.8.1218 · DOI
- Hanka LJ, 1961, Antibiot Chemother, 11, 123
- Hoeksema H, 1975, J Antibiot (Tokyo), 28, 240, 10.7164/antibiotics.28.240 · DOI
- Landini P, 1992, Biochem J, 283, 649, 10.1042/bj2830649 · DOI
- Lewis C, 1961, Antibiot Chemother, 11, 127
- Liljas A, 2000, The Ribosome. Structure, Function, Antibiotics, and Cellular Interactions, 359
- Mason DJ, 1961, Antibiot Chemother, 11, 118
- Nicolaou K, 2005, J Am Chem Soc, 127, 1159
- Ogle J, 2003, TIBS, 28, 259
- Pittenger RC, 1953, Antibiot Chemother, 3, 1268
- Poehlsgaard J, 2003, Curr Opin Investig Drugs, 4, 140
- Rasmussen BA, 1994, Antimicrob Agents Chemother, 38, 1658, 10.1128/AAC.38.7.1658 · DOI
- Shastry M, 2001, Microbiology, 147, 383, 10.1099/00221287-147-2-383 · DOI
- Simonovic M, 2009, Biochim Biophys Acta. Epub ahead of print
- Takeuchi S, 1958, J Antibiot (Tokyo), 11, 1
- Ticu C, 2009, EMBO J 28:2053-2065
- Vannuffel P, 1992, J Biol Chem, 267
- Watanabe T, 1982, J Antibiot (Tokyo), 35, 1141, 10.7164/antibiotics.35.1141 · DOI
- Watanabe T, 1992, J Antibiot (Tokyo), 45, 470, 10.7164/antibiotics.45.470 · DOI
- Weisblum B., 1995, Antimicrob Agents Chemother, 39, 797, 10.1128/AAC.39.4.797 · DOI
- Willcox RR., 1962, Br J Vener Dis, 38, 150
- Wool IG., 1984, TIBS, 9, 14
- 10.2174/0929867013371671 · DOI
- Yamaguchi I, 1975, J Antibiot (Tokyo), 28, 7, 10.7164/antibiotics.28.7 · DOI
- Zaher HS, 2009, Cell, 136, 746, 10.7164/antibiotics.50.514 · DOI
Cited by
Sorted by citations
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Self-citationRevisiting the structures of several antibiotics bound to the bacterial ribosome
Bulkley, D., Innis, C. A., Blaha, G., & Steitz, T. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008685107 · Cited by 308
The bacterial translation stress response.
Starosta, A. L., Lassak, J., Jung, K., & Wilson, D. N. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12083 · Cited by 210
Self-citationStructural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217
Self-citationRetapamulin-Assisted Ribosome Profiling Reveals the Alternative Bacterial Proteome
Meydan, S., Marks, J., Klepacki, D., Sharma, V., Baranov, P. V., Firth, A. E., Margus, T., Kefi, A., Vázquez-Laslop, N., & Mankin, A. S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.017 · Cited by 184
Metadata
- Authors
- Wilson, D. N.
- Affiliations
- Center for Integrated Protein Science Munich (DE)
- Corresponding author
- Wilson, Daniel N.
- ORCID
- Wilson, Daniel N.
- Venue
- Critical Reviews in Biochemistry and Molecular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-11-20
- Volume
- 44
- Issue
- 6
- Pages
- 393-433
- ISSN
- 0045-6411 (ISSN-L)
- 1040-9238
- 1549-7798
- OpenAlex
- W2104276827
- Cited by
- 322
- References
- 369
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 17 · 2020: 17 · 2019: 19 · 2018: 28 · 2017: 13 · 2016: 34 · 2015: 22 · 2014: 22 · 2013: 21 · 2012: 21
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Biochemistry and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- translation inhibitors, antibiotics, bacterial translation, ribosome structure, protein synthesis inhibitors, antibiotic binding sites, mechanism of action, antibiotic resistance, antimicrobial drug development, ribosome-targeted antibiotics
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bacterial Proteins, Humans, Protein Binding, Protein Synthesis Inhibitors, Protein Biosynthesis, Gene Expression Regulation, Bacterial, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review